News

Emmessar Biotech & Nutrition reports standalone net profit of Rs 0.03 crore in the March 2026 quarter

12-May-2026 | 16:14
Sales decline 10.00% to Rs 0.09 crore
Net profit of Emmessar Biotech & Nutrition reported to Rs 0.03 crore in the quarter ended March 2026 as against net loss of Rs 0.07 crore during the previous quarter ended March 2025. Sales declined 10.00% to Rs 0.09 crore in the quarter ended March 2026 as against Rs 0.10 crore during the previous quarter ended March 2025.

For the full year,net profit rose 37.50% to Rs 0.44 crore in the year ended March 2026 as against Rs 0.32 crore during the previous year ended March 2025. Sales declined 39.34% to Rs 0.37 crore in the year ended March 2026 as against Rs 0.61 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.090.10 -10 0.370.61 -39
OPM %-411.11-330.00 --367.57-155.74 -
PBDT0.100.28 -64 0.681.06 -36
PBT0.070.26 -73 0.580.96 -40
NP0.03-0.07 LP 0.440.32 38

Powered by Capital Market - Live News

Close Language Tab
Locate us
Languages
Downloads